At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Double-Blind, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
In Brief
A Phase 2 clinical trial evaluating Ruxolitinib cream and Vehicle cream for Hidradenitis Suppurativa. Completed, enrolled 69 participants across 20 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream in participants with Hidradenitis Suppurativa. This is a randomized 16-week double-blind, vehicle-controlled (DBVC) study followed by a 16 week open label extension period (OLE) with an active treatment for participants who complete the DBVC period.
Study Details
Timeline
Interventions
Ruxolitinib cream is a topical formulation applied as a thin film to affected areas.
Vehicle cream is matching in appearance to ruxolitinib cream and is to be applied in the same manner as ruxolitinib cream.